Patent · US Active

Bisamide sarcomere activating compounds and uses therof

US10723720B2 · kind B2 · utility

5Cited by

3References

21Claims

0Family size

Assignees

AMGEN INC. · US
CYTOKINETICS, INC. · US

Inventors

Luke W. Ashcraft · San Francisco, US
Alessandro Boezio · Somerville, US
John R. BUTLER · Colton, US
Aroop Chandra · South San Francisco, US
Chihyuan Chuang · Millbrae, US
Scott Collibee · South San Francisco, US
Mikkel V. Debenedetto · Shrewsbury, US
Vincent DiMassa · South San Francisco, US
Russell Graceffa · Hampton, US
Justin Malinowski · Boston, US
David Moebius · Westwood, US
Bradley P. Morgan · Moraga, US
Joshua Payette · Hollis, US
Antonio Romero · San Mateo, US
David J. St. Jean, Jr. · Camarillo, US
Richard Vargas · Bedford, US
John Yeoman · Medford, US
Hanmo Zhang · Sharon, US
Alan C. Cheng · Cambridge, US
Felix Gonzalez Lopez De Turiso · Cambridge, US
Michael G. Johnson · San Diego, US

Key dates

Filing date	Sep 13, 2018
Grant date	Jul 28, 2020
Priority date	—
Expiry date	Sep 13, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.